Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients.
Prostate Cancer
; 2015: 285193, 2015.
Article
in En
| MEDLINE
| ID: mdl-25802762
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Prostate Cancer
Year:
2015
Type:
Article
Affiliation country:
United States